HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Sodium Acetate → HCID 178428323, compound

HRID 2046974
Notes
Print preview

Reaction equation

HRID 2046974 reaction equation
[C:1]([C:4]1[C:5](Cl)=[N:6][C:7]([NH:23][C:24]2[C:29]([O:30][CH:31]([CH3:33])[CH3:32])=[CH:28][C:27]([CH:34]3[CH2:39][CH2:38][N:37](C(OC(C)(C)C)=O)[CH2:36][CH2:35]3)=[C:26]([CH3:47])[CH:25]=2)=[N:8][C:9]=1[NH:10][C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=1[S:17]([CH:20]([CH3:22])[CH3:21])(=[O:19])=[O:18])(=O)[CH3:2].[Cl-].[Cl-].[NH2:51][NH2:52].C([O-])(=O)C.[Na+]>CCO>[CH:31]([O:30][C:29]1[CH:28]=[C:27]([CH:34]2[CH2:39][CH2:38][NH:37][CH2:36][CH2:35]2)[C:26]([CH3:47])=[CH:25][C:24]=1[NH:23][C:7]1[N:6]=[C:5]2[NH:51][N:52]=[C:1]([CH3:2])[C:4]2=[C:9]([NH:10][C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=2[S:17]([CH:20]([CH3:22])[CH3:21])(=[O:18])=[O:19])[N:8]=1)([CH3:32])[CH3:33]
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

5

Reactant 3

HCID 517045Sodium AcetateHCID 19367920Hydrazine dichlorideHCID 58290910Tert-butyl 4-(4-(5-acetyl-4-chloro-6-(2-(isopropylsulfonyl)phenylamino)pyrimidin-2-ylamino)-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate

Product 1

HCID 178428323HCID 178428323, compound

Reagents, catalysts & solvents 1

HCID 702
Ethanol
Solvent

Conditions

Temperature
80 °C

Procedure

To a solution of tert-butyl 4-(4-(5-acetyl-4-chloro-6-(2-(isopropylsulfonyl)phenylamino)pyrimidin-2-ylamino)-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate (81 mg, 0.12 mmol) in EtOH (2 mL) was added hydrazine dichloride (36 mg, 0.34 mmoL) and sodium acetate (47 mg, 0.57 mmol) sequentially, and the reaction mixture was heated at 80° C. overnight. The reaction was cooled to room temperature and concentrated in vacuo. The crude was dissolved in the solution of TFA (2 mL) in DCM (2 mL), and the reaction was stirred for 30 min, followed by concentration and purification by RP-HPLC to afford N6-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)-3-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine. MS (ES+): 578.3 (MH+).

Workup

  1. temperatureThe reaction was cooled to room temperature
  2. concentrationconcentrated in vacuo
  3. dissolutionThe crude was dissolved in the solution of TFA (2 mL) in DCM (2 mL)
  4. concentrationfollowed by concentration and purification by RP-HPLC

Sources & evidence

ORD record
ord-53625d08c8584cac9026e13fafd081dd
Source dataset
uspto-grants-2013_11
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08592432B2

Reaction notes

Loading…

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes